Novo Nordisk A/S stock price
NVO
#65

$44.02
  

0.18%

Novo Nordisk A/S Info

Market cap
$194.98B

0.18%

Daily Volume
$611.38M
Asset type
Stocks
Employees
78387
Founded
Dec 21, 1923
Primary exchange
New York Stock Exchange
CIK number
0000353278

Tokenized Stock Data

Avg. Tokenized Price
$44.88
Price Difference
+$0.8593(+1.95%)
Tokenized Mkt Cap
$33.16M

3.42%

Tokenized Vol (24h)
$1.34M

2.39%

Contracts
Explorers
NVO to USD converter
NVO
USD
Price Performance
Low
$43.41
High
$44.59

Loading Data

Please wait a moment.

Novo Nordisk A/S community

skeleton-white
 
 
 
 
 
 

About Novo Nordisk A/S

What is Novo Nordisk A/S?

With roughly one-third of the global branded diabetes treatment market, Novo Nordisk is the leading provider of diabetes care products in the world. Based in Denmark, the company manufactures and markets a variety of human and modern insulins, injectable diabetes treatments such as GLP-1 therapy, oral antidiabetic agents, and obesity treatments. Novo also has a biopharmaceutical segment (contributing less than 10% of revenue) that specializes in protein therapies for hemophilia and other disorders.

Novo Nordisk A/S Price Live Data

The current price of Novo Nordisk A/S in the market is $44.02, with a 24-hour trading volume of $611.38M. The asset's market cap is $194.98B, after moving -0.18% in the last day.

Tokenized Novo Nordisk A/S is trading at $44.88, with a tokenized market cap of $33.16M and a 24-hour trading volume of $1.34M. The tokenized asset has moved 3.42% in the past 24 hours.